Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Burkitt Lymphoma 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Meningeal Carcinomatosis 7Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Acute 5Leukemia, Biphenotypic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Glioblastoma 3Astrocytoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplastic Cells, Circulating 2Meningeal Neoplasms 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Lymphoma 2Glioma 2Brain Neoplasms 2Vomiting 1Uveal Melanoma 1Rhabdomyosarcoma 1Psychomotor Agitation 1Pain, Postoperative 1Oligodendroglioma 1Nevus 1Neoplasm Recurrence, Local 1Multiple Myeloma 1

Interventions

Rituximab 226Cyclophosphamide 202fludarabine phosphate 108Peripheral Blood Stem Cell Transplantation 103Filgrastim 87Etoposide 76Cytarabine 70ibrutinib 68Mycophenolic Acid 67Bortezomib 66Whole-Body Irradiation 63Cyclosporine 63Melphalan 59Lenalidomide 59Bendamustine Hydrochloride 58Vincristine 53Radiotherapy 53fludarabine 52Tacrolimus 50Doxorubicin 48Busulfan 48Methotrexate 47Antilymphocyte Serum 42Prednisone 41Carmustine 40Dexamethasone 38Granulocyte Colony-Stimulating Factor 33venetoclax 31acalabrutinib 31zanubrutinib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, Mantle-Cell × Spinal Puncture × Clear all
NCT05910801 2024-11-18

V-MIND

Academic and Community Cancer Research United

Phase 2 Recruiting
100 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT05936229 2024-07-12

Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy

Fred Hutchinson Cancer Center

Phase 1/2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡